| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8736809 | Clinical Microbiology Newsletter | 2018 | 6 Pages |
Abstract
Development of commercial multiplex panels for the detection and diagnosis of lower respiratory tract infections is rapidly progressing, and FDA-cleared assays are currently available. This review provides a comprehensive overview of the current or soon-to-be available commercial assays, focusing on their analytical performance, advantages, and challenges and the potential impact on patient outcomes when laboratories deploy the assays.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Kevin Alby, Stephanie L. Mitchell,